Stock Taper 
EVERSEPT PARTNERS, LP
Latest 13F filing data - Q2 2026
Holdings
(Top positions)| STOCK | TICKER | SHARES HELD▲ ▼ | VALUE▲ ▼ |
|---|---|---|---|
 Xenon Pharmaceuticals Inc. | XENE | 196.53K | $11.86M |
 Definium Therapeutics, Inc. | DFTX | 217.19K | $10.22M |
 BioMarin Pharmaceutical Inc. | BMRN | 249.61K | $14.28M |
 NewAmsterdam Pharma Company N.V. | NAMS | 275.47K | $9.34M |
 United Therapeutics Corporation | UTHR | 287.67K | $155.87M |
 EyePoint Pharmaceuticals, Inc. | EYPT | 297.74K | $4.26M |
 Mineralys Therapeutics, Inc. | MLYS | 309.69K | $8.36M |
 ARS Pharmaceuticals, Inc. | SPRY | 377.01K | $3.02M |
 Pharvaris N.V. | PHVS | 386.38K | $13.36M |
 LTC Properties, Inc. | LTC | 420.64K | $16.17M |
 AMN Healthcare Services, Inc. | AMN | 428.53K | $13.87M |
 Liquidia Corporation | LQDA | 428.65K | $34.18M |
 Relay Therapeutics, Inc. | RLAY | 434.31K | $8.13M |
 Editas Medicine, Inc. | EDIT | 458.81K | $1.49M |
 The Pennant Group, Inc. | PNTG | 460.27K | $17.01M |
 GSK plc | GSK | 481.83K | $25.26M |
 Omega Healthcare Investors, Inc. | OHI | 483.55K | $23.06M |
 Cogent Biosciences, Inc. | COGT | 490.24K | $18.97M |
 Biohaven Ltd. | BHVN | 515.8K | $7.68M |
 Replimune Group, Inc. | REPL | 590.25K | $6.53M |